![]() |
市場調查報告書
商品編碼
2093436
獸用營養補充品市場-2026-2032年全球市場預測Veterinary Dietary Supplements Market - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,獸用營養補充品市場將成長至 56.7 億美元,複合年成長率為 8.13%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 32.8億美元 |
| 預計年份:2026年 | 35.5億美元 |
| 預測年份 2032 | 56.7億美元 |
| 複合年成長率 (%) | 8.13% |
獸用營養補充品正從可有可無的附加品轉變為動物預防醫學、伴侶動物健康維護、畜牧生產力提升和獸醫診療方案的核心工具。這項需求的促進因素包括寵物飼養量的增加、寵物「人性化」趨勢、伴侶動物壽命的延長、人們對關節、皮膚、消化、免疫、腎臟、心臟和認知健康的日益關注,以及在避免過度依賴治療性介入的同時提高畜群生產力的需求。主要產品類型包括益生菌和益生元、ω脂肪酸、維生素、礦物質、胺基酸、酵素、植物萃取物、抗氧化劑、葡萄糖胺、軟骨素,以及針對犬、貓、馬、家禽、牛、豬、水產養殖和小哺乳動物的特定症狀營養補充劑配方。
在獸用營養補充品領域,一場結構性轉變正在發生,從一般的營養支持轉向以特定症狀為中心的動物健康管理。寵物飼主越來越將補充劑視為日常健康管理的一部分,尤其是在運動功能、消化、皮膚病、壓力管理、免疫力維護和健康老化等領域。同時,獸醫也更有選擇地將補充劑與診斷、處方飲食、復健和慢性病管理相結合,這使得臨床證據、清晰的劑量指南和負責任的療效溝通變得癒發重要。
人工智慧 (AI) 正成為整個獸用營養補充品價值鏈中一股切實的驅動力。在研發領域,AI 驅動的文獻挖掘、配方建模和生物標記分析能夠識別與關節活動度、腸道菌叢平衡、毛髮質量、免疫調節以及物種特異性營養利用相關的成分組合。 AI 工具還可支援快速篩檢原料變異性、穩定性風險、偏好趨勢以及營養功能成分與藥物之間的潛在交互作用。
亞太地區是獸用營養補充品市場最活躍的地區之一,這主要得益於都市區伴侶動物的快速成長、正規獸醫服務的普及以及大規模畜牧和水產養殖的蓬勃發展。在中國、印度、日本、韓國和澳大利亞,高階寵物食品、預防醫學以及肉類畜生產力的提高等因素共同推動了獸用營養補充劑的需求成長。該地區對益生菌、酵素製劑、維生素、礦物質以及用於家禽、乳牛、乳牛和水產養殖系統的飼料添加劑的需求也十分旺盛。這在那些生產者尋求提高飼料轉換率、維護腸道健康以及增強動物對疾病和環境壓力的抵抗力的地區尤其重要。
在東協市場,都市區寵物擁有率的上升、中等收入家庭的擴大以及家禽、生豬和水產養殖業的蓬勃發展,推動了對伴侶動物營養補充劑和飼料中添加營養解決方案的需求。在東協各國,人們越來越重視透過益生菌、酵素、維生素、礦物質、有機酸和免疫支持成分來改善腸道健康、提高抗壓性、促進生長性能和預防疾病。在海灣合作理事會(GCC)地區,高階伴侶動物護理、馬匹健康管理、獵鷹和珍稀動物護理以及不斷擴展的獸醫服務網路發揮著主導作用,消費者對高品質、偏好且具有臨床意義的進口配方表現出濃厚的興趣。
美國仍然是獸用營養補充劑領域極具影響力的國家,這得益於其龐大的寵物數量、先進的獸醫保健網路、廣泛的專業護理以及消費者對寵物健康增強產品的強勁需求。加拿大也體現了類似的對品質和安全的期望,其需求主要由預防性護理、優質寵物營養和透明的標籤資訊所驅動。在墨西哥,伴侶動物照護的擴展以及畜禽養殖業日益成長的需求,為零售寵物補充劑和生產性動物營養創造了商機。巴西作為動物性蛋白質主要生產國和大規模寵物護理市場,非常重視與消化健康、運動表現、皮膚和毛髮護理、運動功能以及預防性獸醫用途相關的補充劑。
行業領導者應優先考慮以證據為基礎的產品開發,投資於物種特異性安全數據、原料標準化、穩定性測試、偏好檢驗和功效聲明。擬供獸醫推薦的產品應包含明確的適應症、基於體重和生命階段的劑量、禁忌症指南以及與飲食和藥物相互作用的注意事項。建立信任需要透明的原料採購、批次間品管、必要的第三方檢測以及符合當地飼料、補充劑和獸藥產品法規的文件。
本執行摘要採用系統的二手研究方法編寫,重點關注經核實且有數據支持的行業信息,這些信息來源於公開的法規結構、獸醫營養指南、動物健康出版物、同行檢驗的科學文獻、政府農業和動物福利資訊來源、貿易數據資料以及可靠的獸醫和飼料行業文件。該調查方法研究途徑強調跨多個資訊來源類別進行三角驗證,以識別需求促進因素、監管趨勢、產品創新、區域滲透率和特定物種營養優先事項方面的一致模式。
獸用營養補充品在現代動物健康管理中扮演著日益重要的角色,它將營養、預防醫學、獸醫護理和生產效率緊密聯繫起來。該領域正從通用營養補充品發展為針對伴侶動物、牲畜、馬匹、水產養殖和特種動物物種的實證、針對性解決方案。推動市場需求的因素包括寵物「人性化」、動物老化、人們對動物福利的期望、合理使用抗生素以及對穩健肉類生產系統的需求。
The Veterinary Dietary Supplements Market is projected to grow by USD 5.67 billion at a CAGR of 8.13% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 3.28 billion |
| Estimated Year [2026] | USD 3.55 billion |
| Forecast Year [2032] | USD 5.67 billion |
| CAGR (%) | 8.13% |
Veterinary dietary supplements are moving from optional add-ons to core tools in preventive animal health, companion animal wellness, livestock productivity, and veterinary practice protocols. Demand is supported by rising pet ownership, humanization of pets, longer companion animal lifespans, growing attention to joint, skin, digestive, immune, renal, cardiac, and cognitive health, and the need to support herd and flock performance without overreliance on therapeutic interventions. Key product categories include probiotics and prebiotics, omega fatty acids, vitamins, minerals, amino acids, enzymes, botanical extracts, antioxidants, glucosamine, chondroitin, and condition-specific nutraceutical formulations for dogs, cats, horses, poultry, cattle, swine, aquaculture, and small mammals.
The sector is shaped by veterinary clinical credibility, ingredient traceability, palatability, formulation science, regulatory compliance, and evidence-based claims. Buyers increasingly seek products backed by safety data, quality certifications, transparent labeling, and professional recommendations. In companion animal channels, e-commerce, subscription models, and veterinary clinics are expanding access, while livestock and equine segments prioritize feed integration, bioavailability, residue safety, and measurable performance outcomes. Across the veterinary dietary supplements landscape, the strongest competitive advantage is shifting toward scientifically substantiated formulations that align with animal life stage, breed, species, condition, and production environment.
The veterinary dietary supplements landscape is undergoing a structural shift from generalized nutrition support to targeted, condition-oriented animal health management. Pet owners are increasingly treating supplements as part of daily wellness routines, particularly for mobility, digestion, dermatology, stress support, immune resilience, and healthy aging. At the same time, veterinarians are using supplements more selectively alongside diagnostics, prescription diets, rehabilitation, and chronic disease management, increasing the importance of clinical rationale, clear dosing guidance, and responsible benefit communication.
Regulatory scrutiny is also transforming the sector. Authorities across major regions continue to distinguish between feed additives, nutraceuticals, veterinary medicines, and therapeutic claims, compelling manufacturers to strengthen label discipline and substantiation. Clean-label expectations, allergen awareness, sustainability claims, and demand for non-GMO, organic, marine-sourced, or plant-based ingredients are influencing product development. In livestock and aquaculture, supplements are increasingly linked to gut health, feed efficiency, stress mitigation, reproductive performance, and reduced antimicrobial pressure, reflecting the global policy focus on antimicrobial stewardship. The most important shift is the convergence of nutrition, veterinary medicine, digital commerce, and precision animal care, where supplements must prove relevance through evidence, convenience, and measurable animal health outcomes.
Artificial intelligence is becoming a practical accelerator across the veterinary dietary supplements value chain. In research and development, AI-enabled literature mining, formulation modeling, and biomarker analysis can help identify ingredient combinations associated with joint mobility, gut microbiome balance, coat quality, immune modulation, and species-specific nutrient utilization. AI tools also support faster screening of raw material variability, stability risks, palatability patterns, and potential interactions between nutraceutical ingredients and medications.
In commercial operations, AI is improving demand sensing, inventory planning, digital merchandising, and customer education while enabling more personalized product recommendations based on species, breed, age, weight, diet type, activity level, and reported health concerns. Veterinary clinics and telehealth platforms can use AI-assisted decision support to triage nutritional questions and encourage appropriate professional oversight, although final recommendations should remain clinician-led. In livestock systems, AI can integrate feed intake, weight gain, milk yield, fertility, environmental stress, and disease indicators to optimize supplement protocols. The cumulative impact of artificial intelligence is not simply automation; it is a shift toward precision supplementation, better compliance monitoring, improved quality assurance, and more evidence-informed decision-making across companion animal and production animal health.
Asia-Pacific is one of the most dynamic regions for veterinary dietary supplements due to rapid companion animal adoption in urban centers, expansion of organized veterinary care, and large-scale livestock and aquaculture production. China, India, Japan, South Korea, and Australia are driving demand through a mix of premium pet nutrition, preventive care, and food animal productivity priorities. The region also has strong relevance for probiotics, enzymes, vitamins, minerals, and feed-based supplements used in poultry, swine, dairy, and aquaculture systems, particularly where producers seek feed efficiency, gut health support, and resilience during disease or environmental stress.
North America demonstrates mature adoption of companion animal supplements, supported by high veterinary service utilization, advanced pet retail channels, strong e-commerce penetration, and consumer familiarity with human nutraceuticals. The United States and Canada show notable demand for joint health, digestive health, dermatology, calming, dental, urinary, renal, and senior pet formulations, with a growing emphasis on quality seals, transparent labels, and veterinarian-endorsed products. Latin America is supported by rising pet ownership, expanding veterinary infrastructure, and significant livestock production in countries such as Brazil and Mexico, where supplements serve both companion animal wellness and production animal nutrition needs.
Europe is characterized by strict regulatory expectations, high animal welfare awareness, and strong demand for scientifically substantiated, traceable, and sustainability-aligned formulations. European buyers are attentive to label claims, ingredient origin, and compliance with feed and veterinary product rules, making quality documentation a key differentiator. The Middle East is emerging through premium pet care growth in urban markets, equine nutrition demand, falcon and specialty animal care, and expanding veterinary services, while Africa presents long-term relevance through livestock health, working animals, poultry production, aquaculture, and gradual development of companion animal care. Across these regions, adoption patterns vary, but the common growth drivers are preventive veterinary care, species-specific nutrition, antimicrobial stewardship, and demand for reliable animal wellness solutions.
ASEAN markets are benefiting from rising urban pet ownership, expanding middle-income households, and strong poultry, swine, and aquaculture activity, creating demand for both companion animal supplements and feed-integrated nutritional solutions. Countries in this group increasingly prioritize gut health, stress resilience, growth performance, and disease prevention through probiotics, enzymes, vitamins, minerals, organic acids, and immune-support ingredients. The GCC is led by premium companion animal care, equine wellness, falcon and specialty animal care, and growing veterinary service networks, with consumers showing interest in imported, high-quality, palatable, and clinically positioned formulations.
The European Union represents one of the most compliance-driven environments for veterinary dietary supplements, where product positioning must align with feed additive regulations, labeling requirements, safety assessments, and restrictions on medicinal claims. This creates strong incentives for evidence-backed claims, traceability, responsible sourcing, and sustainability credentials. BRICS countries combine large pet populations, major livestock sectors, and growing domestic manufacturing capabilities, making them highly relevant for cost-effective, scalable, and species-specific supplement solutions. China, India, Brazil, Russia, and South Africa each present different regulatory and channel realities, but all share increasing attention to animal productivity, food security, antimicrobial stewardship, and companion animal wellness.
G7 countries are distinguished by advanced veterinary care, strong consumer purchasing power, sophisticated retail and digital channels, and higher expectations for clinical validation and product quality. Demand in these countries often centers on premium pet supplements, aging animal care, microbiome support, and condition-specific formulations. NATO member countries overlap with several mature pet care and livestock markets, particularly in North America and Europe, where supply chain resilience, regulatory consistency, biosecurity, and animal health infrastructure influence procurement and distribution. Across these country groups, the leading opportunity lies in adapting formulations, claims, packaging, and channel strategy to local veterinary standards, consumer trust signals, and species priorities.
The United States remains a highly influential country for veterinary dietary supplements, supported by extensive pet ownership, advanced veterinary practice networks, specialty care adoption, and strong consumer demand for pet wellness products. Canada reflects similar quality and safety expectations, with demand shaped by preventive care, premium pet nutrition, and transparent labeling. Mexico combines growing companion animal care with livestock and poultry relevance, creating opportunities for both retail pet supplements and production animal nutrition. Brazil is a major animal protein producer and a large pet care market, making it important for supplements linked to digestive health, performance, skin and coat care, mobility, and preventive veterinary use.
In Europe, the United Kingdom shows strong pet humanization trends and demand for joint, calming, digestive, and senior pet supplements, while Germany emphasizes quality, regulation, sustainability, and scientifically grounded formulations. France has established companion animal care and livestock nutrition demand, with interest in traceable and professionally recommended products. Russia presents demand across pet care, livestock, and equine channels, though supply chain access and regulatory requirements can shape product availability. Italy and Spain demonstrate rising interest in companion animal wellness, palatable formulations, digestive support, and mobility products, supported by active veterinary and pet retail ecosystems.
China is a major growth engine due to expanding pet ownership in urban areas, rapid digital commerce adoption, and large-scale livestock and aquaculture production. India combines one of the world's largest livestock populations with a fast-developing pet care segment, making affordable, robust, and species-appropriate supplements especially relevant. Japan is characterized by an aging pet population, high product quality expectations, and strong demand for senior pet, joint, cognitive, digestive, and renal support. Australia has a mature pet care culture, strong equine and livestock sectors, and high attention to biosecurity and quality. South Korea is driven by premium pet humanization, small-breed dog ownership, e-commerce, and demand for functional products addressing skin, coat, joints, digestion, stress, and aging.
Industry leaders should prioritize evidence-based product development by investing in species-specific safety data, ingredient standardization, stability testing, palatability validation, and claim substantiation. Products positioned for veterinary recommendation should include clear indications, dosing by weight or life stage, contraindication guidance, and compatibility considerations with diets and medications. Building trust requires transparent sourcing, batch-level quality controls, third-party testing where appropriate, and documentation that aligns with local feed, supplement, and veterinary product regulations.
Manufacturers should develop differentiated portfolios around high-need conditions such as mobility, digestive health, dermatology, stress and behavior support, immune resilience, senior pet health, reproductive performance, and production animal gut health. Digital strategy should combine veterinary education, consumer-friendly content, subscription convenience, and post-purchase adherence support without making unsupported therapeutic claims. For livestock and aquaculture channels, companies should link supplementation protocols to practical outcomes such as feed utilization, resilience during environmental stress, welfare indicators, and responsible antimicrobial use. Regionally, success depends on localizing formulations, flavors, pack sizes, price points, documentation, and channel partnerships while maintaining consistent quality governance.
This executive summary is developed through a structured secondary research methodology focused on verified, data-backed industry intelligence from public regulatory frameworks, veterinary nutrition guidelines, animal health publications, peer-reviewed scientific literature, government agriculture and animal welfare sources, trade data references, and reputable veterinary and feed industry documentation. The research approach emphasizes triangulation across multiple source categories to identify consistent patterns in demand drivers, regulatory trends, product innovation, regional adoption, and species-specific nutritional priorities.
The methodology excludes market sizing, share calculation, revenue estimation, and forecasting. Instead, it evaluates qualitative and evidence-supported signals such as pet ownership trends, livestock production relevance, antimicrobial stewardship initiatives, veterinary practice adoption, ingredient science, regulatory classification, labeling standards, and channel evolution. Insights are organized by region, economic group, and key country to support strategic decision-making while avoiding unsupported claims. All findings are interpreted through the lens of veterinary dietary supplements, including companion animal nutraceuticals, feed supplements, functional ingredients, and preventive animal health nutrition.
Veterinary dietary supplements are becoming an increasingly important part of modern animal health management, bridging nutrition, preventive care, veterinary practice, and production efficiency. The sector is advancing beyond generic supplementation toward targeted, evidence-informed solutions for companion animals, livestock, equine, aquaculture, and specialty species. Demand is being reinforced by pet humanization, aging animals, animal welfare expectations, antimicrobial stewardship, and the need for resilient food animal systems.
Future competitiveness will depend on scientific credibility, regulatory discipline, ingredient transparency, formulation precision, and the ability to communicate benefits responsibly. Artificial intelligence, digital commerce, microbiome science, and personalized nutrition are expected to deepen the relevance of supplements across veterinary care pathways. Organizations that combine strong quality systems, clinically meaningful innovation, localized execution, and veterinarian-centered education will be best positioned to build long-term trust in the veterinary dietary supplements landscape.